We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Radiofrequency Ablation System Treats Spinal Tumors

By HospiMedica International staff writers
Posted on 14 Oct 2013
A highly precise ablation system permits minimally invasive targeted tumor necrosis of metastatic spinal tumors.

The Spinal Tumor Ablation with Radiofrequency (STAR) system uses targeted radiofrequency ablation (t-RFA) to deliver energy that heats and destroys the metastatic spinal tumor, providing rapid and lasting pain relief in a single treatment. More...
The bipolar device provides the physician with real-time procedural information using temperature-measuring thermocouples that monitor and adjust, in real time, the RF energy being delivered to the tumor, maximizing tumor destruction while minimizing the risk of impacting healthy surrounding tissue.

During the procedure, the tumor is approached in a uniportal manner with a series of navigational osteotomes and the steerable ablation Instrument. Once positioned appropriately, the articulating electrode of the ablation Instrument is deployed, and RF energy is delivered from the generator directly into the tumor. Local temperatures in and around the ablation zone are continuously displayed and physician controlled at all times. When the required number of RF ablation cycles has been reached, the pedicle access may be closed.

Following ablation with the STAR system, the vertebrae are stabilized with ultra-high viscosity cement; the minimally invasive procedure generally takes about an hour. Unlike patients being treated with radiation therapy for metastatic spinal tumors, those who undergo RF ablation therapy for the same reasons may have no need to delay their systemic and primary cancer regimens. The STAR system is a product of DFine (San Jose, CA, USA), and has received the European community CE mark of approval.

“We are very excited to bring this new treatment modality to Europe so that the hundreds of thousands of patients suffering from painful spinal tumors can receive the rapid pain relief that patients here in the US have experienced. This represents a significant milestone for the company,” said Greg Barrett, CEO of DFine.

Metastatic spinal tumors are a growth of cell mass in or around the vertebra near the spinal cord. It is estimated that 30%–40% of cancer patients will likely develop metastatic spinal tumors. Currently, patients suffering from painful spinal tumors have limited options, and many live in excruciating pain, unable to perform activities of daily living.

Related Links:
DFine


Gold Member
12-Channel ECG
CM1200B
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
X-Ray Generator
Advantage Plus Generators
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The device is worn on a finger and measures blood pressure without an arm‑compressing cuff (Photo courtesy of Sky Labs)

Ring-Type Cuffless Monitor Becomes First Added to Official Hypertension Guidelines

Detecting nocturnal and morning hypertension often requires out-of-office assessment, but conventional cuff-type monitors can disrupt sleep. New national guidance in South Korea expands 24-hour monitoring... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.